Navigation Links
C-Peptide EIA Diabetes and Obesity Markers 008-10-1136-01

ProductsC-Peptide EIA Diabetes and Obesity Markers 008-10-1136-01
Company ALPCO Diagnostics
Item C-Peptide EIA Diabetes and Obesity Markers 008-10-1136-01
Features 
Description Qualitative and quantitative evaluation of pancreatic b-cell function is not only of use in the pre- and post-diagnostic study of the natural history of diabetes mellitus, but is also relevant in clinical practice as a guide to the correct choice of treatment. Peripheral insulin levels cannot be used to assess b-cell function because of the large and variable uptake from the portal circulation into the liver, and because insulin assays cannot distinguish endogenous from exogenous insulin1,3. Human C-peptide is a 31 amino acid chain with a molecular mass of approximately 3020 daltons. Within the pancreatic b-cell, proinsulin is cleaved into one molecule of C-peptide and one molecule of insulin. C-peptide is subsequently released into the circulation at concentrations equimolar to those of insulin. In contrast to insulin, C-peptide is only minimally extracted by the liver. Peripheral C-peptide concentrations therefore reflect the secretion of b-cells more accurately than insulin2,4. The ALPCO C-Peptide ELISA is a solid phase two-site enzyme immunoassay. It is based on the direct sandwich technique in which two monoclonal antibodies are directed against separate antigenic determinants on the C-peptide molecule. During incubation, C-peptide in the sample reacts with peroxidase-conjugated anti-C-peptide antibodies and anti-C-peptide antibodies bound to microplate wells. A simple washing step removes unbound enzyme labeled antibody. The bound conjugate is detected by reaction with 3,3',5,5'-tetramethylbenzidine (TMB). The reaction is stopped by adding acid. The colorimetric endpoint is read spectrophotometrically.
Info ALPCO DiagnosticsCall ALPCO Diagnostics to buy products (US and Canada only; other locations use number below) USACanada1-866-466-7731

Customer Service: (800) 592-5726
Web site: http://www.alpco.com

Related medicine products :

1. Ultrasensitive C-Peptide EIA Diabetes and Obesity Markers 008-10-1141-01
2. C-Peptide
3. ADVIA Centaur C-Peptide Assay
4. C-Peptide Chemiluminescence Immunoassay
5. ACS:180 C-Peptide Assay
6. C-Peptide of Insulin ELISA Test
7. C-Peptide of Insulin RIA Test
8. C-Peptide, 24-Hour Urine
9. C-Peptide, Serum or Plasma
10. Iso-Insulin EIA Diabetes and Obesity Markers 008-10-1128-01
11. Insulin Ultrasensitive EIA Diabetes and Obesity Markers 008-10-1132-01
... The UST-9123 transducer is ALOKAs ... imaging transducer.,This wide-band, Super High ... transducer is multi-frequency, offering 5 ... addition to 4 settings of ...
TOX/See is a 1-step, hand-held, point-of-care device for the qualitative detection of drug or drug metabolites in human urine....
... by PerkinElmer,is a complete fiber ... Xenon technology.,Cermax Xenon is the ... into endoscopy,equipment and other demanding,medical ... illumination.,It provides many advantages for,the ...
... The OPTI LION is a compact ... single-use cassettes instead of reagents or ... patient sample is analyzed., ,In addition ... the OPTI LION measures ionized calcium ...
Medicine Products:
(Date:5/21/2015)... York (PRWEB) May 21, 2015 World ... patented products, launches the Troll Motor Guide, a boat ... of boating. , "The recreational boating industry has reached ... Cooper, CEO and Creative Director of World Patent ... record numbers and predicts continued steady growth of seven ...
(Date:5/21/2015)... 21, 2015 Absolute Exhibits, a ... interactive, state-of-the-art website that is filled with essential exhibiting ... resource information. With its original and inventive design ideas, ... The website shows hundred of pictures of client- owned ... This is not an exhibit rendering site, rather real-time ...
(Date:5/21/2015)... ChiliPad is a temperature-regulated mattress ... of the bed so that users sleep comfortably all ... the bed can pick their ideal sleep temperature and ... and stay asleep longer. , Unlike other products, ChiliPad ... temperature which produces a more concentrated temperature than circulated ...
(Date:5/21/2015)... New York (PRWEB) May 21, 2015 ... Atmananda Yoga Studio and Sequence, is excited to ... Yoga Mat™, which was previously available for use exclusively ... Yoga Mat™ unique is that it's mathematically designed ... serious joint injuries and muscle strains, commonly experienced ...
(Date:5/21/2015)... ANN ARBOR, Mich. (PRWEB) May 21, 2015 ... having the opposite effect on those with celiac disease ... . More than half of the probiotics tested in ... present in foods and dietary supplements and cause gastrointestinal ... sensitivity. , Companies aiming to gain consumer trust in ...
Breaking Medicine News(10 mins):Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 3Health News:New Convention and City Travel Guides Within the Absolute Exhibits’ Website 2Health News:ChiliPad, a Dual-Zone Temperature-Controlled Mattress Pad, Promotes Better Sleep, Health Benefits, and Saves on Cooling Costs in Upcoming Hot Summer Weather 2Health News:ChiliPad, a Dual-Zone Temperature-Controlled Mattress Pad, Promotes Better Sleep, Health Benefits, and Saves on Cooling Costs in Upcoming Hot Summer Weather 3Health News:NY's Atmananda Yoga Studio Launches Its Patented "Alignment" Yoga Mat for Public Sale 2Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 2Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 3Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 4
... are awarded to community programs with which employees ... $7,000 in grants to 14 nonprofit organizations across ... its employees. Grants were awarded to programs that ... values among youth, offer care for animals, assist ...
... to chronic cardiac insufficiency if it is suppressed, ... the Internal Medicine Clinic at Heidelberg University Hospital in ... Medical Center at Dallas and Gttingen University Hospital have ... and thus discovered a promising approach for the systematic ...
... Vetmedin(R) proven to nearly double life expectancy of dogs ... 17 A break-through drug to treat congestive heart ... United States. Boehringer Ingelheim Vetmedica, Inc. (BIVI) is the ... new drug approved by the FDA in over a ...
... the training of local eye health workers, providing free ... YORK, Feb. 17 ORBIS International and FedEx (NYSE: ... eye health training to local ophthalmic communities in Santo ... - March 6, 2009. Utilizing ORBIS International,s flagship Flying ...
... in the Los Angeles area as the Colgate-Palmolive Company ... to the La Canada,and Pacoima Big Lots stores on ... http://www.newscom.com/cgi-bin/prnh/20011026/BIGLOTSLOGO ) , ... van and its team,of dental professionals will provide free ...
... Mo. More than 30 years ago the ... and research of ancient Asian medical practices including ... study at the University of Missouri, researchers discovered ... a significant reduction in pain, had fewer requests ...
Cached Medicine News:Health News:Highmark Employee Volunteers Receive $7,000 in Grants to Support Local Nonprofits 2Health News:Highmark Employee Volunteers Receive $7,000 in Grants to Support Local Nonprofits 3Health News:Highmark Employee Volunteers Receive $7,000 in Grants to Support Local Nonprofits 4Health News:Highmark Employee Volunteers Receive $7,000 in Grants to Support Local Nonprofits 5Health News:Enzyme weakens the heart 2Health News:Break-through Drug for Heart Failure in Dogs Now Available in the United States 2Health News:Break-through Drug for Heart Failure in Dogs Now Available in the United States 3Health News:ORBIS and FedEx Launch Sight-Saving Programs to Combat Avoidable Blindness in Latin America & the Caribbean 2Health News:ORBIS and FedEx Launch Sight-Saving Programs to Combat Avoidable Blindness in Latin America & the Caribbean 3Health News:ORBIS and FedEx Launch Sight-Saving Programs to Combat Avoidable Blindness in Latin America & the Caribbean 4Health News:Colgate's Bright Smiles, Bright Futures Program Brings Free Children's Dental Screenings to Los Angeles Area Big Lots Stores 2Health News:MU researcher demonstrates non-traditional therapy is effective as pain management 2
(Date:5/21/2015)...  CryoLife, Inc. (NYSE: CRY ), a leading ... and vascular surgery, announced today that its Board of ... second quarter 2015 of $0.03 per share of common ... share will be paid on June 19, 2015 to ... 2015.  The ex-dividend date for the quarterly dividend is ...
(Date:5/21/2015)... Mai 2015 Dipexium Pharmaceuticals, ... Unternehmen für Arzneimittel im fortgeschrittenen Entwicklungsstadium, ... Vermarktung von Locilex® (Pexiganan-Creme 0,8 %) und ... wissenschaftliche Posterpräsentation an, welche das innovative ... OneStep-1 und OneStep-2, in der Locilex® ...
(Date:5/21/2015)... May 21, 2015  Today, eight groups ... prescribe biologics – Alliance for Patient Access, ... of Rheumatology, Biologics Prescribers Collaborative, Clinical Immunology ... Society, and North American Society for Pediatric ... letter to U.S. Food and Drug Administration ...
Breaking Medicine Technology:CryoLife Announces Quarterly Cash Dividend for the Second Quarter 2015 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 4Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 5Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 6Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 7Physician Groups Urge FDA to Ensure Patient Safety With Greater Transparency in Biosimilar Labeling 2Physician Groups Urge FDA to Ensure Patient Safety With Greater Transparency in Biosimilar Labeling 3Physician Groups Urge FDA to Ensure Patient Safety With Greater Transparency in Biosimilar Labeling 4